publication venue for
- Priovi appears to be a valuable digital tool for patients with borderline personality disorder.. 12. 2025
- Clinical symptoms and psychosocial functioning in patients with schizophrenia spectrum disorders testing seropositive for anti-NMDAR antibodies: a case-control comparison with patients testing negative.. 11. 2024
- Efficacy of oral versus long-acting antipsychotic treatment in patients with early-phase schizophrenia in Europe and Israel: a large-scale, open-label, randomised trial (EULAST).. 10. 2023
- Efficacy and safety of the novel glycine transporter inhibitor BI 425809 once daily in patients with schizophrenia: a double-blind, randomised, placebo-controlled phase 2 study.. 8. 2021
- Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial.. 7. 2020
- Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study.. 5. 2018
- EFFECT OF PREOPERATIVE PAIN AND DEPRESSIVE SYMPTOMS ON THE DEVELOPMENT OF POSTOPERATIVE DELIRIUM.. 1. 2014
- Infant autism: parents' role in ameliorating risk?. 2. 2015
- Pharmacological treatment of psychotic depression. 2024
- Recognising the heterogeneity of autism. 2019
- The use of long-acting injectables in early-phase schizophrenia - Authors' reply. 2023
- Prolonged grief disorder. 2022
- The Lancet Psychiatry Commission: transforming mental health implementation research. 2024
- Relapse in clinically stable adult patients with schizophrenia or schizoaffective disorder: evidence-based criteria derived by equipercentile linking and diagnostic test accuracy meta-analysis. 2023
- Mental health research in the Arab region: challenges and call for action. 2019